Take a holistic approach to genomic testing reimbursement
To get to the root of existing reimbursement problems, health plans should consider tackling genomic benefits management in a way that addresses test ordering and billing challenges.
Foundation Medicine, Epic partner to integrate genomic insights into EHR
As a result of the partnership, clinicians using Epic will be able to order Foundation Medicine's genomic profiling tests directly from the EHR and view results in the system, providing them with clinical decision support.
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
NHS invests $300M in the development of new AI capabilities
The National AI lab is meant to support clinicians in efforts to estimate future needs of healthcare resources, identify the best sites of care for patients and help automate routine and administrative tasks to increase system efficiency.
23andMe gets FDA nod for new Colorectal cancer indication test
The company used its previous authorization for breast cancer genetic screening as a predicate for its 510(k) approval.
CMS gives a big boost to broad genomic tests by widening coverage for sequencing
Foundation Medicine and ThermoFisher Scientific are big beneficiaries of CMS widening its coverage and making a national coverage decision for next-generation sequencing of metastatic, Stage 3 or 4 and other cancers.
Guardant Health announced an almost $100M Series D round for its cancer blood test
The Redwood City, Calif.-based company has raised nearly $100 million in Series D financing led by OrbiMed Advisors.
presented by
Transforming Patient Care: The Role of AI-Powered Assistants
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
FDA launches precisionFDA, a platform for collaboration to increase DNA data
The FDA is embracing precision medicine with its new platform designed to allow scientists to share next-generation sequencing data.
GuardantHealth, Flatiron Health to link genomics, analytics for personalized cancer care
In a further sign of the convergence happening in healthcare technology, genomics company GuardantHealth is teaming with health IT and analytics vendor Flatiron Health to create a new platform to enable personalized cancer care.
Study: Customers of commercial genomic testing services understand results more than expected
For average people without a science or healthcare background, genetic testing results would seemingly be difficult to understand, but that might not be the case.